Bicycle Therapeutics Plc Adr (BCYC)

Jun 27, 2026

Price to earnings forward of Bicycle Therapeutics Plc Sponsored ADR – FWB:50BA - TradingView

Jun 27, 2026

Jun 27, 2026

Enterprise value to EBIT forward of Bicycle Therapeutics Plc Sponsored ADR – FWB:50BA - TradingView

Jun 27, 2026

Jun 27, 2026

Bicycle Therapeutics Plc Sponsored ADR Actuals & Estimates (NASDAQ:BCYC) - TradingView

Jun 27, 2026

Jun 26, 2026

Price to sales forward of Bicycle Therapeutics Plc Sponsored ADR – FWB:50BA - TradingView

Jun 26, 2026

Jun 26, 2026

50BA Forecast — Price Target — Prediction for 2027 - TradingView

Jun 26, 2026

Jun 18, 2026

Bicycle Therapeutics shareholders approve all proposals at annual general meeting - Investing.com South Africa

Jun 18, 2026

May 19, 2026

Bicycle Therapeutics’ SWOT analysis: stock navigates trial delays - Investing.com

May 19, 2026

May 15, 2026

After plunging 20.2% in 4 weeks, here's why the trend might reverse for Bicycle Therapeutics (BCYC) - MSN

May 15, 2026

May 01, 2026

Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC) Sees Significant Increase in Short Interest - MarketBeat

May 01, 2026

Apr 30, 2026

Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2026 Financial Results - ChartMill

Apr 30, 2026

Apr 30, 2026

Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Apr 30, 2026

Apr 27, 2026

Bicycle Therapeutics (BCYC) loses 19.0% in 4 weeks, here's why a trend reversal may be around the corner - MSN

Apr 27, 2026

Apr 22, 2026

Bicycle Therapeutics (BCYC) schedules 2026 AGM with director, pay and auditor votes - Stock Titan

Apr 22, 2026

Apr 21, 2026

Peptide Drug Conjugate Market Landscape Report 2026: A $1.5 Billion Opportunity by 2031 - GlobeNewswire Inc.

Apr 21, 2026

Apr 20, 2026

Bicycle Therapeutics doses first patient in pancreatic cancer trial By Investing.com - Investing.com South Africa

Apr 20, 2026

Apr 20, 2026

Bicycle Therapeutics doses first patient in pancreatic cancer trial - Investing.com

Apr 20, 2026

Apr 16, 2026

Wall Street Analysts Believe Bicycle Therapeutics (BCYC) Could Rally 137.88%: Here's is How to Trade - Yahoo Finance

Apr 16, 2026

Apr 06, 2026

Bicycle Therapeutics (NASDAQ:BCYC) CEO Kevin Lee Sells 5,967 Shares of Stock - MarketBeat

Apr 06, 2026

Apr 05, 2026

Bicycle Therapeutics plc (BCYC) stock price, news, quote and history - Yahoo Finance UK

Apr 05, 2026

Apr 05, 2026

Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC) Receives Consensus Rating of "Hold" from Analysts - MarketBeat

Apr 05, 2026

Apr 03, 2026

Bicycle Therapeutics (BCYC) proxy: June 17 AGM, board and pay votes (BCYC) - Stock Titan

Apr 03, 2026

Mar 24, 2026

After Plunging 20.2% in 4 Weeks, Here's Why the Trend Might Reverse for Bicycle Therapeutics (BCYC) - Yahoo Finance

Mar 24, 2026

Mar 23, 2026

Bicycle Therapeutics (BCYC) Drops 19.0% Over the Past 4 Weeks, Reasons a Potential Turnaround Could Be Near - Bitget

Mar 23, 2026

Mar 23, 2026

Bicycle Therapeutics (BCYC) Loses 19.0% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance

Mar 23, 2026

Mar 19, 2026

Bicycle Therapeutics (NASDAQ:BCYC) Given New $15.00 Price Target at Needham & Company LLC - Defense World

Mar 19, 2026

Mar 19, 2026

Bicycle Therapeutics (NASDAQ:BCYC) Given New $36.00 Price Target at Oppenheimer - Defense World

Mar 19, 2026

Mar 18, 2026

Bicycle Therapeutics stock price target lowered to $7 by RBC Capital - Investing.com South Africa

Mar 18, 2026

Mar 18, 2026

Citizens cuts Bicycle Therapeutics stock price target on strategic shift By Investing.com - Investing.com South Africa

Mar 18, 2026

Mar 18, 2026

Bicycle Therapeutics (BCYC) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat

Mar 18, 2026

Mar 17, 2026

Truist cuts Bicycle Therapeutics stock price target on pipeline shift By Investing.com - Investing.com South Africa

Mar 17, 2026

Mar 17, 2026

Morgan Stanley reiterates Bicycle Therapeutics stock rating on program shift By Investing.com - Investing.com India

Mar 17, 2026

Mar 17, 2026

Morgan Stanley reiterates Bicycle Therapeutics stock rating on program shift - Investing.com

Mar 17, 2026

Mar 11, 2026

Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Mar 11, 2026

Mar 11, 2026

Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World

Mar 11, 2026

Feb 27, 2026

SUNation Energy Inc. (NASDAQ:SUNE) Short Interest Update - Defense World

Feb 27, 2026

Feb 14, 2026

Denali Therapeutics Inc. (NASDAQ:DNLI) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

Feb 14, 2026

Feb 14, 2026

Definium Therapeutics, Inc. (NASDAQ:DFTX) Receives Average Rating of “Buy” from Brokerages - Defense World

Feb 14, 2026

Feb 14, 2026

Merit Medical Systems, Inc. (NASDAQ:MMSI) Receives Average Rating of “Moderate Buy” from Analysts - Defense World

Feb 14, 2026

Feb 13, 2026

Principal Financial Group Inc. Grows Position in Bicycle Therapeutics PLC Sponsored ADR $BCYC - MarketBeat

Feb 13, 2026